Intravenöösi metoproli versus amiodaroni sydänleikkauksen jälkeisen eteisvärinän estossa: vertaileva tutkimus tehosta, sivuvaikutuksista ja kustannuksista

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-004918-40-FI

Enrollment

270

Registered

2006-09-06

Start date

2006-10-06

Completion date

Unknown

Last updated

2025-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MCC, lusuff.valv. aortae, stenosis valv. aortae MedDRA version: 8.1 Level: LLT Classification code 10016566 Term: Fibrillation atrial

Interventions

Trade Name: seloken Product Name: seloken Pharmaceutical Form: Intravenous infusion CAS Number: 54163881 Other descriptive name: METOPROLOL Trade Name: Cordarone Product Name: COrdarone Pharmaceutica

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: MCC, lusuff.valv. aortae, stenosis valv. aortae;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026